Filing Details
- Accession Number:
- 0000937556-25-000098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-03 17:38:10
- Reporting Period:
- 2025-07-01
- Filing Date:
- 2025-07-03
- Accepted Time:
- 2025-07-03 17:38:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1933567 | Neuraxis Inc | NRXS | Electromedical & Electrotherapeutic Apparatus (3845) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 937556 | Masimo Corp | 52 Discovery Irvine CA 92618 | No | No | Yes | No |
Transaction Summary
| Sold: | 821,327 shares | Avg. Price: $2.25 | Total Value: $1,847,985.75 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-01 | 531,548 | $2.25 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-07-01 | 289,779 | $0.00 | 289,779 | No | 4 | C | Direct | |
| Common Stock | Disposition | 2025-07-01 | 289,779 | $2.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | C | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Pre-Funded Warrant, Common Stock (Right to Buy) | Disposition | 2025-07-01 | 289,779 | $0.00 | 289,779 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.0005 per share of the Issuer's Common Stock.
Billionaire Hedge Funds
